M Castañeda-Ávila, A Cruz-Benítez, W Fuentes-Payán, A Maldonado-Albertorio, L Nieves-Ferrer, P Padró-Juarbe, R Soto-Abreu, N Pérez-Ríos, C R Torres-Cintrón, K J Ortiz-Ortiz, A P Ortiz Martinez
{"title":"Epidemiology of Pancreatic Cancer in Puerto Rico (1987-2010): Incidence, Mortality and Survival.","authors":"M Castañeda-Ávila, A Cruz-Benítez, W Fuentes-Payán, A Maldonado-Albertorio, L Nieves-Ferrer, P Padró-Juarbe, R Soto-Abreu, N Pérez-Ríos, C R Torres-Cintrón, K J Ortiz-Ortiz, A P Ortiz Martinez","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background & objective: </strong>Pancreatic cancer is an uncommon type of cancer worldwide. Nonetheless, even with early diagnosis, mortality rates are high. This study aims to perform an epidemiologic profile of pancreatic cancer in Puerto Rico (PR) from 1987-2010.</p><p><strong>Methods: </strong>Using data from the Puerto Rico Central Cancer Registry, age-standardized incidence and mortality rates of pancreatic cancer in PR were compared with Hispanics, non-Hispanic Whites, and non-Hispanic Blacks in the United States of America (USA). Incidence and mortality trends of pancreatic cancer were estimated, and survival analyses were also performed.</p><p><strong>Results: </strong>In 2005-2010, 5.8 per 100,000 persons were diagnosed with pancreatic cancer in PR and mortality rates were similar. Pancreatic cancer was more frequent in men (6.5 per 100,000 men) than women (5.2 per 100,000 women), and in persons older than 65 years (32.0 per 100,000 persons). Moreover, the median survival for the people diagnosed with pancreatic cancer in PR during 2006-2007 was 4 months and at the end of the third year after diagnosis, only 13% of the patients survived. Incidence trends of pancreatic cancer showed an increase for men (APC=13.0%, p<0.05) from 2006 to 2010, but not for women (APC=-0.4, p>0.05). However, mortality trends showed a slight decrease for men (APC=-1.0%, p<0.05), but not for women (APC=1.4, p>0.05) in the period of 1987 to 2010. Meanwhile, Puerto Ricans in comparison to other racial/ethnic groups living in the USA showed a lower risk for being diagnosed and of dying from pancreatic cancer.</p><p><strong>Conclusion: </strong>Our results highlight the need for additional research in pancreatic cancer, in order to have an impact in disease survival in PR.</p>","PeriodicalId":93268,"journal":{"name":"Austin journal of gastroenterology","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341429/pdf/nihms-1725421.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39292225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}